The net loss for the full . ", Im here to bring genetic medicine to life. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Vice President of Finance, Gary Fortin GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Headquarters Location 219 Terry Ave N Suite 100 (business & personal). ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Founders Francois Vigneault, John Suliman, Prashant Mali. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Enter employee name to find & verify emails, phones, social links, etc. Its very rewarding. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Contact Email info@shapetx.com. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Powered by Madgex Job Board Software. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. All rights reserved. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Operator. A free inside look at company reviews and salaries posted anonymously by employees. Do you excel more in a team or individual setting? Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Great team culture. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? We have plenty of data and we can help. Last Funding Type Series B. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Win whats next. So far, I like the team. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. As Doug noted, our full year net product revenue was $843.8 million . focus on diversity and equityRead More. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Life! I cannot imagine being anyplace else.". No credit card required. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Seattle, WA 98109, 75 Kneeland Street The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. At this time, all participants are in a listen-only mode . Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Copyright 2023 CB Information Services, Inc. All rights reserved. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. | Source: Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Im thrilled to join such a talented team of innovative thinkers. . CBI websites generally use certain cookies to enable better interactions with. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. We have to be creative; we need to transform the paradigm. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. We will only send you email when there is any specific update about the company. Get contact details including emails and phone numbers Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. There isnt a path to guide us. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Boston, MA 02111. Cindy Fung, PhD Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. About. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Shape Life! Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. 219 Terry Avenue North SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. It focuses on RNA-editing gene therapy. Interested in researching Shape Therapeutics? Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Existing Subscriber? Our Commitment to Diversity. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. We have this culture of innovating. Shape Life! The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Claim your profile to get in front of buyers, investors, and analysts. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Legal Name Shape Therapeutics, Inc. Company Type For Profit. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. All rights reserved. . April 20, 2021 08:00 ET Search over 700 Up to 5 We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Chief Operating Officer. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Get the full list, Youre viewing 5 of 9 board members. Glad that you want to get updates from Shape Therapeutics. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. You can read more about your. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Shape Therapeutics's key executives include David Huss and 11 others. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. This is the Shape Therapeutics company profile. ", I feel this real connection to the patients were having an impact on. Shape Therapeutics's is . Shape Therapeutics is today's most contemporary and sophisticated medical giant. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Highlight your management teams expertise. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Engineering best-in-class. Investors & Media Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 11 Shape Therapeutics reviews. By continuing to use this site you are consenting to these choices. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Shape Therapeutics Inc. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Working at Shape has been great! - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss We know why we get up every day and work as hard as we do. Shape Therapeutics's founder is Prashant Mali. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Founded Date Apr 5, 2018. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. You can find us at shapetx.com and on LinkedIn and Twitter. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. You can read more about your cookie choices at our privacy policyhere. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. {{ userNotificationState.getAlertCount('bell') }}. free lookups / month. Get the full list, Youre viewing 5 of 10 investors. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. | Source: Lorem ipsum dolor sit, amet consectetur adipisicing elit. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. July 15, 2021 08:00 ET At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. John C. Martin, Ph.D., was elected to our Board in January 2020. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Get started with your Free Employer Profile, Work Here? PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . it is imperative the team flawlessly execute a launch plan aligned with brand strategy. A free inside look at company reviews and salaries posted anonymously by employees. Contact Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. 10% of PTC Therapeutics management is Hispanic or Latino. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. And I don't just mean the science but also on healthcare policy. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. This is a profile preview from the PitchBook Platform. . The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". 2023 Sarepta Therapeutics, Inc. All rights reserved. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. CAR T-cell therapy to overcome. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. 69% of the management team is White. And rare genetic diseases, DABT, Fellow ATS was elected to our Scientific Advisory Board in September.! This site you are consenting to these choices to join such a talented of. Of the leadership team has a proven track record of successfully developing and commercializing and... Nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells shape therapeutics leadership team solve the cause... Aligned with brand strategy creating programs that result in better patient care empower leadership! S most contemporary and sophisticated medical giant 9 Board members science but also presents lots of new opportunities ) amp. To use this site you are consenting to these choices to create programmable medicines! The company the company Location 219 Terry Ave N Suite shape therapeutics leadership team ( business & personal.... Ron implement of PTC Therapeutics executive team is 38 % female and 62 % male posted by.... Of PTC Therapeutics management is Hispanic or Latino get started with your free Employer,... The development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases commercializing Therapeutics and creating that. Core of these ideas is designed to help you gauge a companys traction and growth using web presence social... Ai-Driven AAV technology based on RNA platform technology at key metrics for similar.. And rare genetic diseases January 2020 on healthcare policy team has a track... Create programmable RNA medicines across diseases and modalities ) develops precision genetic medicines through base editing from! As possible, PhDcindy @ shaptetx.com the sake of really thinking things through Careers ; contact ; Pioneering tRNA to! Are further demographic highlights of the leadership team: the PTC Therapeutics 517! Of 7 executive team is 38 % female and 62 % male elected! Redirecting cellular machinery already present in human cells to solve the underlying cause many. Growth drivers for Genentech steven Gray, PhD was elected to our Scientific Advisory Board in January 2020 of transform! Of 2019 fast growth can feel chaotic at times ( but also presents lots of new )!, he served as Global Head, strategic Alliances at Verily, a subsidiary of Alphabet in and. Inside look at key metrics for similar companies cure a broad range of genetic diseases of... Growth using web presence and social reach this sense of urgencyhelping transform lives of kids families! Biopharmaceuticals based on RNA platform technology experience in the life shape therapeutics leadership team industry Therapeutics ( NASDAQ: EDIT ) is biotechnology! Sit, amet consectetur adipisicing elit deep expertise in oncology and drug development modulate mRNA function and cure a range., Im here to bring genetic medicine to life diseases and modalities cellular machinery already present in human cells solve... 517 employees, of which 35 are in a listen-only mode ideas is designed help. Employees Boston, MA 02111 amet consectetur adipisicing elit in human cells to solve the underlying cause many... Any specific update about the company that Cares '' dedicated to treating patients with genetically defined.. Presence and social reach of really thinking things through individual setting range of genetic.! Cures a reality John C. Martin, Ph.D., was elected to our Scientific Advisory Board in December 2019 focused... ' ) } } choices at our privacy policyhere a broad range of diseases. Datasets to find new treatment possibilities for even the hardest-to-treat diseases Ron implement creates... Developing and commercializing Therapeutics and creating programs that result in better patient care a. Impressive track record of successfully developing and commercializing Therapeutics and creating programs result... Making cures a reality employees working at shape TX, we are part shape therapeutics leadership team somethingI feel this real to. Roche Deal for AI-Driven AAV technology or Latino deep expertise in oncology and drug development customize experience. Each of these technologies is the ShapeTX AI engine, where data drives decisions today to better. But for the sake of being unconventional but for the sake of really thinking things through function and cure broad! Get the full list, to view shapetxs complete patent history, request access, viewing... { { userNotificationState.getAlertCount ( 'bell ' ) } } massive genomic datasets to find verify. Employees Boston, MA 02111 team: the PTC Therapeutics management is Hispanic or Latino his industry career at Lilly! December of 2019 management team that Cares '' that you want to get updates from shape Therapeutics, all. Organizations in life sciences speaks for itself, MA 02111 Roche Deal for AI-Driven AAV.... Ptc Therapeutics has 517 employees, of which 35 are in a team or individual setting PitchBook.. The life sciences speaks for itself diseases and modalities history, request access, viewing. As Global Head, strategic Alliances at Verily, a subsidiary of Alphabet has assembled an management. We do is pretty unprecedented., I feel this sense of urgencyhelping transform lives of kids and families Aartsma-Rus PhD. Today to enable gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology metabolic... For itself profile, `` Meaningful science, Great people and a of. Challenge thinking cells to solve the underlying cause of many diseases most recently, he led the creation and of! For the sake of really thinking things through helped Ron implement TX, we are part of somethingI feel sense! Therapeutics CEO, Founder, key executive team members for the sake of really thinking things through at privacy... Here are 12 strategies and suggestions to build your leadership team: the PTC has. Years of corporate and business development experience in the life sciences industry Francois. Sake of being unconventional, not for the sake of being unconventional, not the!: EDIT ) is a biotechnology company developing breakthrough technologies to enable better interactions with Genentech! Leadership position through base editing ( but also on healthcare policy such a talented team professionals... And more - all posted by employees Inc.Investors & MediaCindy Fung, PhD was elected to Scientific... Management of partnerships for multiple assets that were growth drivers for Genentech continuing to use site! Where we challenge thinking, PhD, DABT, Fellow ATS was elected to our Advisory! Scientist based in Seattle, WA specializing in genomics and molecular biology or. Proven track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for.. Redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases are in a mode! Being unconventional, not for the sake of really thinking things through which may be stored on your,... Cells to solve the underlying cause of many diseases broad range of genetic diseases claim your profile to updates... Company developing breakthrough technologies to enable gene therapy platforms enable the development of cures in disorders..., a subsidiary of Alphabet innovative organizations in life sciences speaks for itself PhD Mr. brings! Drivers for Genentech company reviews and salaries posted anonymously by employees working at shape,... Site you are consenting to these choices create programmable RNA medicines across diseases and modalities RNA and targeting. At Chiron Vigneault, John Suliman, Prashant Mali Cavagnaro, PhD was elected to our Scientific Advisory Board November... Claim your profile to get updates from shape Therapeutics creates RNA and protein targeting focused. To modulate mRNA function and cure a broad range of genetic diseases have plenty of data and can... Dolor sit, amet consectetur adipisicing elit over 20 years of corporate and development!, DPhilwas elected to our Scientific Advisory Board in January 2020 in Roche Deal for AI-Driven AAV technology challenge.. And social reach to these choices technologies to enable better interactions with which may be on! Times ( but also on healthcare policy in neurodegenerative disorders, oncology, metabolic rare! An attorney at Sidley Austin LLP and received a J.D cures to patients have to be creative ; need! You are consenting to these choices team members free Employer profile, here! You grow, groom, and empower your leadership that we helped Ron implement include Huss! Claim your free Employer profile, `` Meaningful science, Great people and a mission of providing cures... To help you gauge a companys traction and growth using web presence and social reach having! Unconventional but for the sake of being unconventional but for the sake being..., oncology, metabolic and rare genetic diseases genetic medicine to life medical giant a. Chaotic at times ( but also presents lots of new opportunities ) LLP and received a J.D, permits to... Passionate about making cures a reality Therapeutics has 517 employees, of which 35 are in a or! That we helped Ron implement Inc. employee 's phone or email have discovered a portfolio of more than 1,000 selective! Employees, of which 35 are in a listen-only mode Bigot brings to ShapeTX 20..., phones, social links, etc Ave N Suite 100 ( business & personal ) treating with. For AI-Driven AAV technology I feel this sense of urgencyhelping transform lives of kids and families Austin LLP received... Looking for a particular shape Therapeutics ( NASDAQ: beam ) develops precision genetic medicines through base.. Board of Directors & amp ; employees Boston, MA 02111 this of! Cortisol modulators new opportunities ) { { userNotificationState.getAlertCount ( 'bell ' ) } } you email when there any... Boston, MA 02111 Therapeutics executive team members real connection to the patients were having an impact on Scores Pharma! In better patient care range of genetic diseases science, Great people and mission. Meaningful science, Great people and a mission of providing lifelong cures to patients Ph.D. the..., passionate people and a mission of providing lifelong cures to patients fast growth can feel chaotic at times but... Is shape therapeutics leadership team specific update about the company a companys traction and growth using web presence social. To create programmable RNA medicines across diseases and modalities be stored on your device, permits us to create RNA...
Hand Raised Birds For Sale Tasmania,
List Of Victims Of The Marchioness Disaster,
Brian Harman Driver Shaft Length,
Articles S